ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

South Carolina Clinic and Anil Potti Part Ways

February 24, 2012

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

NIH Begins Process Of Extramural Program “Reinvention”

July 22, 1994

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975